Animesh Jain

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

Animesh Jain, Evan J. Lipson, William H. Sharfman et al. · World Journal of Gastroenterology · 2017 · 79 citations · Full text

Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases

Animesh Jain, Nghia Nguyen, J. Proudfoot et al. · The American Journal of Gastroenterology · 2019 · 74 citations

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 61 citations

Urology, Moxibustion, Gastroenterology +6

Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn’s Disease Patients

Matt Kanke, Meaghan M. Kennedy Ng, Sean V. Connelly et al. · Cellular and Molecular Gastroenterology and Hepatology · 2022 · 54 citations · Full text